Actos Lawsuit Center
Free Actos Bladder Cancer Lawsuit Review

Bookmark and Share



Actos Bladder Cancer Lawsuit Case Review
Martindale Hubbell AV Rated Law Firm
Multi-Million Dollar Advocates Forum Members
SuperLawyers at The Onder Law Firm

Actos Bladder Cancer Lawsuits Filed After FDA Issues Warning Regarding Increased Risk of Bladder Cancer from Using the Diabetes Drug Actos

Actos Bladder Cancer

Actos (pioglitazone) is a diabetes drug marketed by Takeda Pharmaceuticals that has been linked to increased risk of bladder cancer for years and was recently pulled from the market in a number of countries. Actos was recalled in France because of the increased bladder cancer risk. Although the FDA has issued an Actos bladder cancer warning, the drug remains in use in the United States. Many of the persons using Actos who developed bladder cancer have now filed one of thousands of Actos bladder cancer lawsuits.

The market for diabetes drugs is huge, with the best selling diabetes drug typically exceeding annual sales of $2 billion just in the United States. Actos, recently the most popular diabetes drug in the U.S. had annual sales of more than $6 billion. This is despite early knowledge that Actos could increase the risk of bladder cancer - Actos bladder cancer was detected during initial animal testing - and that Actos bladder cancer rates were known to be higher than the incidence of bladder cancer for other diabetes medications. Just as the diabetes drug Avandia, taken off the market for its role in causing heart attacks, strokes and other forms of cardiovascular disease, resulted in thousands of lawsuits, so could Actos bladder cancer. Given that more than 2 million people filled Actos or Actoplus prescriptions in 2010 in the United States, the forthcoming Actos bladder cancer lawsuits will likely be in the thousands..

This website provides information about Actos, bladder cancer, when it was known that Actos could increase the risk of bladder cancer, the Actos bladder cancer FDA warning and what rights you and your family may have if you or a loved one developed bladder cancer after taking Actos.


Actos Bladder Cancer Lawsuits

If you developed bladder cancer after taking Actos to control your diabetes you maybe be able to file an Actos bladder cancer lawsuit. Our attorneys are offering a free, no-obligation Actos bladder cancer lawsuit review to persons diagnosed with bladder cancer after taking Actos. An Actos bladder cancer lawsuit may enable some to receive more advanced treatment for their bladder cancer as well as cover lost wages and compensate for the pain associated with bladder cancer and cancer treatment along with the immeasurable suffering that comes with any cancer diagnosis.


Actos Bladder Cancer Information

Actos Bladder Cancer

Multiple clinical studies, by both the manufacturer of Actos and independent entities, have demonstrated that rates of bladder cancer in those taking Actos are higher than those taking other diabetes medications. Bladder cancer was in fact detected in the earliest Actos test subjects. This section includes information on the studies that have shown Actos increases bladder cancer risks, who is most at risk of Actos bladder cancer and bladder cancer treatment.


Actos FDA Cancer Warning

Actos FDA Warnings
The FDA has issued three safety notifications for Actos. Two of those warnings, issued within the last 12 months, focused solely on Actos bladder cancer. Read important safety information in the FDA Actos bladder cancer warning, what steps drug regulatory agencies in other countries have taken regarding Actos bladder cancer and how the Actos label was recently updated to include bladder cancer information in the Warnings and Precautions section.


Actos Lawsuit FAQs

Actos Cancer FAQs - Actos Cancer Lawsuit FAQs

This section answers questions about Actos bladder cancer, who can file an Actos lawsuit and the steps to do so, why Actos lawsuits are not class action lawsuits and answers to other Actos bladder cancer lawsuit questions you may have.


Mass Tort Web Site Design and Marketing by Gudeman Group